Head and Neck Cancer Trial, Recruiting (NCT05995821)

Head and Neck Cancer Trial, Recruiting NCT05995821 Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Condition: Head and Neck Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05995821 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Head And Neck Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with, or are suspected of having, a cancer of the upper airways or digestive tract, and who may be receiving treatments that could affect the immune system
People who are able to understand the study information and are willing to sign a consent form

Who may not be able to join:

People with known medical reasons that make blood draws unsafe (for example, very low haemoglobin levels) may not be able to take part in the blood collection part of the study
People with known medical reasons that make tissue biopsies unsafe (for example, serious bleeding problems) may not be able to take part in the biopsy part of the study
People with known medical reasons that make a bronchoscopy (a procedure to look inside the airways) unsafe (for example, airway problems or significant heart disease) may not be able to take part in that part of the study
People who are unable or unwilling to read English and complete study forms and questionnaires

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Valsamo Anagnostou, MD, PhD, Johns Hopkins University

Phone: 410-614-8948

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05995821

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase: Not Applicable

Status: Recruiting

Condition: Head and Neck Cancer

Trial contact: 410-614-8948

More information: https://clinicaltrials.gov/study/NCT05995821

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with, or are suspected of having, a cancer of the upper airways or digestive tract, and who may be receiving treatments that could affect the immune system
People who are able to understand the study information and are willing to sign a consent form

Who may not be able to join:

People with known medical reasons that make blood draws unsafe (for example, very low haemoglobin levels) may not be able to take part in the blood collection part of the study
People with known medical reasons that make tissue biopsies unsafe (for example, serious bleeding problems) may not be able to take part in the biopsy part of the study
People with known medical reasons that make a bronchoscopy (a procedure to look inside the airways) unsafe (for example, airway problems or significant heart disease) may not be able to take part in that part of the study
People who are unable or unwilling to read English and complete study forms and questionnaires

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Registry

ClinicalTrials.gov

Start date

25 August 2016

Est. completion

25 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Demographic and clinical data obtained via chart review; Biological specimens obtained from cancer patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov